[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"facial-nerve-paralysis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:facial-nerve-paralysis":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100637028","validation-of-artificial-intelligence-based-facial-paralysis-assessment-in-patients-with-bells-palsy-100637028",false,"NCT07573358","Validation of Artificial Intelligence-Based Facial Paralysis Assessment in Patients With Bell's Palsy","AI-FACE","Inclusion Criteria:\n\n* Patients with unilateral Bell's palsy.\n* Patients must be within one month of onset of Bell's palsy symptoms at the time of enrollment.\n* Body mass index (BMI) less than 30 $kg\u002Fm\\^2$.\n* Patients must be cooperative and able to follow simple verbal instructions during facial movement tasks.\n\nExclusion Criteria:\n\n* Bilateral facial paralysis or recurrent Bell's palsy.\n* Facial nerve palsy due to known secondary causes (e.g., trauma, neoplasm, infection, stroke, Ramsay Hunt syndrome, or otitis media).\n* Facial deformities, scars, or burns that interfere with facial motion detection.\n* Uncooperative or cognitively impaired individuals unable to follow instructions or maintain required facial postures.","ALL","25 Years","40 Years",{"count":20,"type":21},63,"ESTIMATED","OBSERVATIONAL","This observational study aims to assess the concurrent validity of an artificial intelligence (AI)-based facial paralysis assessment system in patients with unilateral Bell's palsy. Currently, clinical assessment relies on subjective scales like the Sunnybrook Facial Grading System, which can vary between different observers. This study will compare AI-generated composite asymmetry scores-derived from real-time computer vision analysis of facial landmarks-with scores from the Sunnybrook system. The goal is to determine if AI can provide a valid, objective method for monitoring facial nerve recovery.",[25,26],"Bell's Palsy","Facial Nerve Paralysis",[28,29,30,31],"Facial Asymmetry","Artificial Intelligence","Sunnybrook Facial Grading System","Computer Vision","NOT_YET_RECRUITING","2026-05-01",{"date":35,"type":36},"2026-05-07","ACTUAL",{"date":38,"type":21},"2026-06-01",{"date":40,"type":21},"2026-12-01",{"name":42,"class":43},"Cairo University","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":44},"100601923","phase-3-steroids-for-facial-nerve-function-protection-in-post-surgical-vestibular-schwannoma-patients-100601923","NCT07116811","Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients","The Effect of Steroids Treatment for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients (SAF-NRVS): a Multicenter, Randomized, Double-blind, Placebo-parallel Controlled Trial","SAF-NRVS","Inclusion Criteria:\n\n1. Age between 18 and 60 years\n2. Diagnosed with untreated unilateral vestibular schwannoma\n3. No facial palsy before surgery (House-Brackmann grade I)\n4. Intraoperative neurophysiological monitoring confirms good facial nerve function preservation, defined as: a）Post-tumor resection, evoked compound muscle action potential amplitude \\>420 μV under 0.05 mA stimulation；and b）The amplitude is \\>60% of baseline value measured before dural opening\n5. Signed informed consent\n\nExclusion Criteria:\n\n1. Contraindications for craniotomy\n2. Patients requiring corticosteroids during the perioperative period, or with known corticosteroid contraindications\n3. Patients or first-degree relatives with a confirmed diagnosis of neurofibromatosis type 2 (NF2)\n4. Karnofsky Performance Status (KPS) score \\\u003C90 before disease onset\n5. Pregnant or planning to become pregnant during the study period\n6. Participation in other interventional clinical trials\n7. Judged unsuitable by the investigators","18 Years","60 Years",{"count":56,"type":21},364,"INTERVENTIONAL",[59],"PHASE3","The purpose of this study is to evaluate the efficacy and safety of steroids treatment compared with placebo in preserving facial nerve function after craniotomy in patients with vestibular schwannoma who have not received preoperative treatment and have good intraoperative facial nerve function.",[62,26],"Vestibular Schwannoma",[64,65,66,67,68],"Steroids","Facial Nerve Function","Intraoperative Neurophysiological Monitoring","Randomized Controlled Trial","Facial Palsy","2025-08-07",{"date":71,"type":36},"2025-08-12",{"date":73,"type":21},"2025-09-01",{"date":75,"type":21},"2027-09-30",{"name":77,"class":43},"Beijing Tiantan Hospital"]